BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 8599182)

  • 21. A new structurally atypical bradykinin-potentiating peptide isolated from Crotalus durissus cascavella venom (South American rattlesnake).
    Lopes DM; Junior NE; Costa PP; Martins PL; Santos CF; Carvalho ED; Carvalho MD; Pimenta DC; Cardi BA; Fonteles MC; Nascimento NR; Carvalho KM
    Toxicon; 2014 Nov; 90():36-44. PubMed ID: 25091347
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bradykinin potentiating and sensitizing activities of new synthetic analogues of snake venom peptides.
    Sabia EB; Tominaga M; Paiva AC; Paiva TB
    J Med Chem; 1977 Dec; 20(12):1679-81. PubMed ID: 592335
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Peptide T, a novel bradykinin potentiator isolated from Tityus serrulatus scorpion venom.
    Ferreira LA; Alves EW; Henriques OB
    Toxicon; 1993 Aug; 31(8):941-7. PubMed ID: 8212046
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Potentiation of bradykinin by inhibitors of angiotensin converting enzyme.
    Ryan JW; Carlin G; Berryer P; Chung A
    Adv Exp Med Biol; 1983; 156():613-20. PubMed ID: 6190380
    [No Abstract]   [Full Text] [Related]  

  • 25. ESI-MS/MS identification of a bradykinin-potentiating peptide from Amazon Bothrops atrox snake venom using a hybrid Qq-oaTOF mass spectrometer.
    Coutinho-Neto A; Caldeira CA; Souza GH; Zaqueo KD; Kayano AM; Silva RS; Zuliani JP; Soares AM; Stábeli RG; Calderon LA
    Toxins (Basel); 2013 Feb; 5(2):327-35. PubMed ID: 23430539
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Primary structure and biological activity of bradykinin potentiating peptides from Bothrops insularis snake venom.
    Cintra AC; Vieira CA; Giglio JR
    J Protein Chem; 1990 Apr; 9(2):221-7. PubMed ID: 2386615
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bradykinin-potentiating activity of captopril disulphide dimer (SQ 14,551).
    Drummer OH; Kourtis S
    Eur J Pharmacol; 1988 Aug; 153(1):11-7. PubMed ID: 3063549
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative effects of two potentiating peptides (KPP and BPP9a) on kinin-induced rat paw edema.
    Fernandes PD; Guimarães JA; Assreuy J
    Agents Actions; 1991 Mar; 32(3-4):182-7. PubMed ID: 1862741
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bradykinin-potentiating peptides: beyond captopril.
    Camargo AC; Ianzer D; Guerreiro JR; Serrano SM
    Toxicon; 2012 Mar; 59(4):516-23. PubMed ID: 21835190
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The kallikrein, kininase and related peptides activities in central Asian snake venoms.
    Yukelson LYa ; L'vov VM; Shkinev AV; Sultanalieva N
    Agents Actions Suppl; 1992; 38 ( Pt 1)():430-40. PubMed ID: 1334625
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The effect of potentiating factors on the bradykinine effect in vitro].
    Paegelow I; Reissmann S; Arold H
    Acta Biol Med Ger; 1976; 35(2):235-44. PubMed ID: 1033653
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Isolation: analysis and properties of three bradykinin-potentiating peptides (BPP-II, BPP-III, and BPP-V) from Bothrops neuwiedi venom.
    Ferreira LA; Galle A; Raida M; Schrader M; Lebrun I; Habermehl G
    J Protein Chem; 1998 Apr; 17(3):285-9. PubMed ID: 9588953
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Potentiation of bradykinin action on smooth muscle by a scorpion venom extract.
    Araujo RL; Gomez MV
    Gen Pharmacol; 1976 Aug; 7(2-3):123-6. PubMed ID: 976731
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biochemical and pharmacological aspects of two bradykinin-potentiating peptides obtained from tryptic hydrolysis of casein.
    Perpetuo EA; Juliano L; Lebrun I
    J Protein Chem; 2003 Nov; 22(7-8):601-6. PubMed ID: 14714726
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bradykinin potentiating factor.
    Greene LJ; Ferreira SH; Stewart JM
    Chest; 1971 May; 59():Suppl:9S-10S. PubMed ID: 4325034
    [No Abstract]   [Full Text] [Related]  

  • 36. Synthesis and pharmacological screening of new angiotensin converting enzyme inhibitors.
    Gubert S; Braso MA; Sacristán A; Ortiz JA
    Farmaco; 1990 Jan; 45(1):59-79. PubMed ID: 2186741
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of the conversion of angiotensin I to II and potentiation of bradykinin by small peptides present in Bothrops jararaca venom.
    Greene LJ; Camargo AC; Krieger EM; Stewart JM; Ferreira SH
    Circ Res; 1972 Sep; 31(9):Suppl 2:62-71. PubMed ID: 4341481
    [No Abstract]   [Full Text] [Related]  

  • 38. Effect of stretching on the sensitivity of the guinea pig ileum to bradykinin and on its modification by bradykinin potentiating peptides.
    Shimuta SI; Sabia EB; Paiva AC; Paiva TB
    Eur J Pharmacol; 1981 Apr; 70(4):551-8. PubMed ID: 7238576
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Kallikrein-kinin system in the plasma of the snake Bothrops jararaca.
    Abdalla FM; Hiraichi E; Picarelli ZP; Prezoto BC
    Br J Pharmacol; 1989 Sep; 98(1):252-8. PubMed ID: 2804549
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel bradykinin potentiating peptide isolated from Bothrops jararacussu venom using catallytically inactive oligopeptidase EP24.15.
    Rioli V; Prezoto BC; Konno K; Melo RL; Klitzke CF; Ferro ES; Ferreira-Lopes M; Camargo AC; Portaro FC
    FEBS J; 2008 May; 275(10):2442-54. PubMed ID: 18400032
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.